特許医薬品の世界市場レポート2020

• 英文タイトル:Global Patent Medicine Sales Market Report 2020

Global Patent Medicine Sales Market Report 2020「特許医薬品の世界市場レポート2020」(市場規模、市場予測)調査レポートです。• レポートコード:QY20ST-05716
• 出版社/出版日:QYResearch / 2020年9月17日
• レポート形態:英文、PDF、131ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥416,000 (USD4,000)▷ お問い合わせ
  Multi User¥624,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥832,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の特許医薬品市場について種類別(製品特許、プロセス特許)、用途別(大人、子供)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・特許医薬品市場の概要
・世界の主要地域別特許医薬品市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の特許医薬品市場規模2015-2026:種類別(製品特許、プロセス特許)
・世界の特許医薬品市場規模2015-2026:用途別(大人、子供)
・特許医薬品の北米市場規模2015-2020
・特許医薬品のヨーロッパ市場規模2015-2020
・特許医薬品の中国市場規模2015-2020
・特許医薬品の日本市場規模2015-2020
・特許医薬品の東南アジア市場規模2015-2020
・特許医薬品のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・特許医薬品の製造コスト分析
・販売チャネル、流通業者、顧客
・特許医薬品の市場動向・機会・課題
・調査の結論

Today many drug companies which have produced drugs with which the public is very familiar, like Plavix®, Lipitor® and Abilify® 

Market Analysis and Insights: Global Patent Medicine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Patent Medicine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Patent Medicine industry.
Based on our recent survey, we have several different scenarios about the Patent Medicine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Patent Medicine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Patent Medicine Scope and Market Size
The global Patent Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Patent Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Patent Medicine market is segmented into
Product Patents
Process Patents

Segment by Application, the Patent Medicine market is segmented into
Adult
Children

The Patent Medicine market is analysed and market size information is provided by regions (countries). Segment by Application, the Patent Medicine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Patent Medicine Market Share Analysis
Patent Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Patent Medicine business, the date to enter into the Patent Medicine market, Patent Medicine product introduction, recent developments, etc.

The major vendors covered:
Pfizer Inc.
Otsuka Pharmaceutical
Merck
Novartis
Sanofi-Aventis
Bristol-Myers Squibb Co.
GSK

レポート目次

1 Patent Medicine Market Overview
1.1 Patent Medicine Product Scope
1.2 Patent Medicine Segment by Type
1.2.1 Global Patent Medicine Sales by Type (2020-2026)
1.2.2 Product Patents
1.2.3 Process Patents
1.3 Patent Medicine Segment by Application
1.3.1 Global Patent Medicine Sales Comparison by Application (2020-2026)
1.3.2 Adult
1.3.3 Children
1.4 Patent Medicine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Patent Medicine Sales Growth Rate (2015-2026)
1.4.2 Global Patent Medicine Revenue and Growth Rate (2015-2026)
1.4.3 Global Patent Medicine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Patent Medicine Industry Impact
1.5.1 How the Covid-19 is Affecting the Patent Medicine Industry
1.5.1.1 Patent Medicine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Patent Medicine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Patent Medicine Players to Combat Covid-19 Impact

2 Patent Medicine Estimate and Forecast by Region
2.1 Global Patent Medicine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Patent Medicine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Patent Medicine Sales Market Share by Region (2015-2020)
2.2.2 Global Patent Medicine Revenue Market Share by Region (2015-2020)
2.3 Global Patent Medicine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Patent Medicine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Patent Medicine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Patent Medicine Estimates and Projections (2015-2026)
2.4.2 Europe Patent Medicine Estimates and Projections (2015-2026)
2.4.3 China Patent Medicine Estimates and Projections (2015-2026)
2.4.4 Japan Patent Medicine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Patent Medicine Estimates and Projections (2015-2026)
2.4.6 India Patent Medicine Estimates and Projections (2015-2026)
3 Global Patent Medicine Competition Landscape by Players
3.1 Global Top Patent Medicine Players by Sales (2015-2020)
3.2 Global Top Patent Medicine Players by Revenue (2015-2020)
3.3 Global Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patent Medicine as of 2019)
3.4 Global Patent Medicine Average Price by Company (2015-2020)
3.5 Manufacturers Patent Medicine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Patent Medicine Players (Opinion Leaders)
4 Global Patent Medicine Market Size by Type
4.1 Global Patent Medicine Historic Market Review by Type (2015-2020)
4.1.1 Global Patent Medicine Sales Market Share by Type (2015-2020)
4.1.2 Global Patent Medicine Revenue Market Share by Type (2015-2020)
4.1.3 Global Patent Medicine Price by Type (2014-2020)
4.2 Global Patent Medicine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Patent Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Patent Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Global Patent Medicine Price Forecast by Type (2021-2026)
5 Global Patent Medicine Market Size by Application
5.1 Global Patent Medicine Historic Market Review by Application (2015-2020)
5.1.1 Global Patent Medicine Sales Market Share by Application (2015-2020)
5.1.2 Global Patent Medicine Revenue Market Share by Application (2015-2020)
5.1.3 Global Patent Medicine Price by Application (2015-2020)
5.2 Global Patent Medicine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Patent Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Patent Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Patent Medicine Price Forecast by Application (2021-2026)

3 North America Patent Medicine Market Facts & Figures
3.2 North America Patent Medicine Sales Market Share by Company (2015-2020)
3.3 North America Patent Medicine Sales Market Share by Type (2015-2020)
3.4 North America Patent Medicine Sales Market Share by Application (2015-2020)

4 Europe Patent Medicine Market Facts & Figures
4.2 Europe Patent Medicine Sales Market Share by Company (2015-2020)
4.3 Europe Patent Medicine Sales Market Share by Type (2015-2020)
4.4 Europe Patent Medicine Sales Market Share by Application (2015-2020)

5 China Patent Medicine Market Facts & Figures
5.2 China Patent Medicine Sales Market Share by Company (2015-2020)
5.3 China Patent Medicine Sales Market Share by Type (2015-2020)
5.4 China Patent Medicine Sales Market Share by Application (2015-2020)

6 Japan Patent Medicine Market Facts & Figures
6.2 Japan Patent Medicine Sales Market Share by Company (2015-2020)
6.3 Japan Patent Medicine Sales Market Share by Type (2015-2020)
6.4 Japan Patent Medicine Sales Market Share by Application (2015-2020)

7 Southeast Asia Patent Medicine Market Facts & Figures
7.2 Southeast Asia Patent Medicine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Patent Medicine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Patent Medicine Sales Market Share by Application (2015-2020)

8 India Patent Medicine Market Facts & Figures
8.2 India Patent Medicine Sales Market Share by Company (2015-2020)
8.3 India Patent Medicine Sales Market Share by Type (2015-2020)
8.4 India Patent Medicine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Patent Medicine Business
12.1 Pfizer Inc.
12.1.1 Pfizer Inc. Patent Medicine Corporation Information
12.1.2 Pfizer Inc. Patent Medicine Business Overview and Total Revenue
12.1.3 Pfizer Inc. Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Inc. Patent Medicine Products Offered
12.1.5 Pfizer Inc. Recent Development
12.2 Otsuka Pharmaceutical
12.2.1 Otsuka Pharmaceutical Patent Medicine Corporation Information
12.2.2 Otsuka Pharmaceutical Patent Medicine Business Overview and Total Revenue
12.2.3 Otsuka Pharmaceutical Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Otsuka Pharmaceutical Patent Medicine Products Offered
12.2.5 Otsuka Pharmaceutical Recent Development
12.3 Merck
12.3.1 Merck Patent Medicine Corporation Information
12.3.2 Merck Patent Medicine Business Overview and Total Revenue
12.3.3 Merck Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Patent Medicine Products Offered
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Patent Medicine Corporation Information
12.4.2 Novartis Patent Medicine Business Overview and Total Revenue
12.4.3 Novartis Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Patent Medicine Products Offered
12.4.5 Novartis Recent Development
12.5 Sanofi-Aventis
12.5.1 Sanofi-Aventis Patent Medicine Corporation Information
12.5.2 Sanofi-Aventis Patent Medicine Business Overview and Total Revenue
12.5.3 Sanofi-Aventis Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi-Aventis Patent Medicine Products Offered
12.5.5 Sanofi-Aventis Recent Development
12.6 Bristol-Myers Squibb Co.
12.6.1 Bristol-Myers Squibb Co. Patent Medicine Corporation Information
12.6.2 Bristol-Myers Squibb Co. Patent Medicine Business Overview and Total Revenue
12.6.3 Bristol-Myers Squibb Co. Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb Co. Patent Medicine Products Offered
12.6.5 Bristol-Myers Squibb Co. Recent Development
12.7 GSK
12.7.1 GSK Patent Medicine Corporation Information
12.7.2 GSK Patent Medicine Business Overview and Total Revenue
12.7.3 GSK Patent Medicine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GSK Patent Medicine Products Offered
12.7.5 GSK Recent Development

13 Patent Medicine Manufacturing Cost Analysis
13.1 Patent Medicine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Patent Medicine
13.4 Patent Medicine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Patent Medicine Distributors List
14.3 Patent Medicine Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Patent Medicine Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Patent Medicine Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Patent Medicine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Patent Medicine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Patent Medicine Players to Combat Covid-19 Impact
Table 8. Global Market Patent Medicine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Patent Medicine Sales (K Doses) by Region (2015-2020)
Table 10. Global Patent Medicine Sales Market Share by Region (2015-2020)
Table 11. Global Patent Medicine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Patent Medicine Revenue Share by Region (2015-2020)
Table 13. Global Patent Medicine Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Patent Medicine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Patent Medicine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Patent Medicine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Patent Medicine (K Doses) of Key Companies (2015-2020)
Table 18. Global Patent Medicine Sales Share by Company (2015-2020)
Table 19. Global Patent Medicine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Patent Medicine Revenue Share by Company (2015-2020)
Table 21. Global Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patent Medicine as of 2019)
Table 22. Global Patent Medicine Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Patent Medicine Manufacturing Sites and Area Served
Table 24. Manufacturers Patent Medicine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Patent Medicine Players
Table 27. Global Patent Medicine Sales (K Doses) by Type (2015-2020)
Table 28. Global Patent Medicine Sales Share by Type (2015-2020)
Table 29. Global Patent Medicine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Patent Medicine Price (K Doses) by Type (2015-2020)
Table 31. Global Patent Medicine Sales Share by Type (2021-2026)
Table 32. Global Patent Medicine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Patent Medicine Revenue Share by Type (2021-2026)
Table 34. Global Patent Medicine Price (K Doses) by Type (2021-2026)
Table 35. Global Patent Medicine Sales (K Doses) by Application (2015-2020)
Table 36. Global Patent Medicine Sales Share by Application (2015-2020)
Table 37. Global Patent Medicine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Patent Medicine Price (K Doses) by Application (2015-2020)
Table 39. Global Patent Medicine Sales (K Doses) by Application (2021-2026)
Table 40. Global Patent Medicine Sales Share by Application (2021-2026)
Table 41. Global Patent Medicine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Patent Medicine Revenue Share by Application (2021-2026)
Table 43. Global Patent Medicine Price (K Doses) by Application (2021-2026)
Table 44. United States Patent Medicine Sales (K Doses) by Company (2015-2020)
Table 45. United States Patent Medicine Sales Market Share by Company (2015-2020)
Table 46. United States Patent Medicine Sales (K Doses) by Type (2015-2020)
Table 47. United States Patent Medicine Sales Market Share by Type (2015-2020)
Table 48. United States Patent Medicine Sales (K Doses) by Application (2015-2020)
Table 49. United States Patent Medicine Sales Market Share by Application (2015-2020)
Table 50. Europe Patent Medicine Sales (K Doses) by Company (2015-2020)
Table 51. Europe Patent Medicine Sales Market Share by Company (2015-2020)
Table 52. Europe Patent Medicine Sales (K Doses) by Type (2015-2020)
Table 53. Europe Patent Medicine Sales Market Share by Type (2015-2020)
Table 54. Europe Patent Medicine Sales (K Doses) by Application (2015-2020)
Table 55. Europe Patent Medicine Sales Market Share by Type (2015-2020)
Table 56. China Patent Medicine Sales (K Doses) by Company (2015-2020)
Table 57. China Patent Medicine Sales Market Share by Company (2015-2020)
Table 58. China Patent Medicine Sales (K Doses) by Type (2015-2020)
Table 59. China Patent Medicine Sales Market Share by Type (2015-2020)
Table 60. China Patent Medicine Sales (K Doses) by Application (2015-2020)
Table 61. China Patent Medicine Sales Market Share by Application (2015-2020)
Table 62. Japan Patent Medicine Sales (K Doses) by Company (2015-2020)
Table 63. Japan Patent Medicine Sales Market Share by Company (2015-2020)
Table 64. Japan Patent Medicine Sales (K Doses) by Type (2015-2020)
Table 65. Japan Patent Medicine Sales Market Share by Type (2015-2020)
Table 66. Japan Patent Medicine Sales (K Doses) by Application (2015-2020)
Table 67. Japan Patent Medicine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Patent Medicine Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Patent Medicine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Patent Medicine Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Patent Medicine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Patent Medicine Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Patent Medicine Sales Market Share by Application (2015-2020)
Table 74. India Patent Medicine Sales (K Doses) by Company (2015-2020)
Table 75. India Patent Medicine Sales Market Share by Company (2015-2020)
Table 76. India Patent Medicine Sales (K Doses) by Type (2015-2020)
Table 77. India Patent Medicine Sales Market Share by Type (2015-2020)
Table 78. India Patent Medicine Sales (K Doses) by Application (2015-2020)
Table 79. India Patent Medicine Sales Market Share by Application (2015-2020)
Table 80. Pfizer Inc. Corporation Information
Table 81. Pfizer Inc. Description and Business Overview
Table 82. Pfizer Inc. Patent Medicine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Pfizer Inc. Patent Medicine Product
Table 84. Pfizer Inc. Recent Development
Table 85. Otsuka Pharmaceutical Corporation Information
Table 86. Otsuka Pharmaceutical Description and Business Overview
Table 87. Otsuka Pharmaceutical Patent Medicine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Otsuka Pharmaceutical Patent Medicine Product
Table 89. Otsuka Pharmaceutical Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Patent Medicine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Merck Patent Medicine Product
Table 94. Merck Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Patent Medicine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Novartis Patent Medicine Product
Table 99. Novartis Recent Development
Table 100. Sanofi-Aventis Corporation Information
Table 101. Sanofi-Aventis Description and Business Overview
Table 102. Sanofi-Aventis Patent Medicine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Sanofi-Aventis Patent Medicine Product
Table 104. Sanofi-Aventis Recent Development
Table 105. Bristol-Myers Squibb Co. Corporation Information
Table 106. Bristol-Myers Squibb Co. Description and Business Overview
Table 107. Bristol-Myers Squibb Co. Patent Medicine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Bristol-Myers Squibb Co. Patent Medicine Product
Table 109. Bristol-Myers Squibb Co. Recent Development
Table . GSK Corporation Information
Table . GSK Description and Business Overview
Table . GSK Patent Medicine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . GSK Patent Medicine Product
Table . GSK Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Patent Medicine Distributors List
Table 118. Patent Medicine Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Patent Medicine Product Picture
Figure 2. Global Patent Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Patent Medicine Market Share by Application in 2020 & 2026
Figure 6. Adult Examples
Figure 7. Children Examples
Figure 8. Global Patent Medicine Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Patent Medicine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Patent Medicine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Patent Medicine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Patent Medicine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Patent Medicine Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Patent Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Patent Medicine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Patent Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Patent Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Patent Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Patent Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Patent Medicine Players Market Share by Revenue in Patent Medicine 2015 & 2019
Figure 26. Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Patent Medicine Revenue Share by Type (2015-2020)
Figure 28. Global Patent Medicine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Patent Medicine Revenue Share by Application (2015-2020)
Figure 30. Global Patent Medicine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Patent Medicine Sales Market Share by Type in 2019
Figure 32. United States Patent Medicine Sales Market Share by Type in 2019
Figure 33. Europe Patent Medicine Sales Market Share by Company in 2019
Figure 34. Europe Patent Medicine Sales Market Share by Type in 2019
Figure 35. Europe Patent Medicine Sales Market Share by Application in 2019
Figure 36. China Patent Medicine Sales Market Share by Company in 2019
Figure 37. China Patent Medicine Sales Market Share by Type in 2019
Figure 38. China Patent Medicine Sales Market Share by Application in 2019
Figure 39. Japan Patent Medicine Sales Market Share by Company in 2019
Figure 40. Japan Patent Medicine Sales Market Share by Type in 2019
Figure 41. Japan Patent Medicine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Patent Medicine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Patent Medicine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Patent Medicine Sales Market Share by Application in 2019
Figure 45. India Patent Medicine Sales Market Share by Company in 2019
Figure 46. India Patent Medicine Sales Market Share by Type in 2019
Figure 47. India Patent Medicine Sales Market Share by Application in 2019
Figure 48. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Otsuka Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bristol-Myers Squibb Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Patent Medicine
Figure 57. Manufacturing Process Analysis of Patent Medicine
Figure 58. Patent Medicine Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed



• 英文レポート名:Global Patent Medicine Sales Market Report 2020
• 日本語訳:特許医薬品の世界市場レポート2020
• レポートコード:QY20ST-05716お問い合わせ(見積依頼・ご注文・質問)